Cardiovascular Systems (CSII) Tops Q2 EPS by 3c, Offers Q3 Guidance

Cardiovascular Systems (NASDAQ: CSII) reported Q2 EPS of ($0.47), $0.03 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $41.4 million versus the consensus estimate of $44.82 million.

GUIDANCE:

Cardiovascular Systems sees Q3 2016 EPS of ($0.42)-($0.45), versus the consensus of ($0.45). Cardiovascular Systems sees Q3 2016 revenue of $40.5-42 million, versus the consensus of $45.8 million.

For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• Ennis (EBF) Reports In-Line Q1 EPS